-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CZRh4Q0YR+jmnjS4JbPeeO5uMN5SMqLYPzNlvse2g3LK6tFwnAQas0nrFL0seRV9 lmocsaSv8U41XTSNwdJ6Vw== 0001157523-06-001798.txt : 20060221 0001157523-06-001798.hdr.sgml : 20060220 20060221142035 ACCESSION NUMBER: 0001157523-06-001798 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20060215 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060221 DATE AS OF CHANGE: 20060221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVEX INC CENTRAL INDEX KEY: 0000050601 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 411223933 STATE OF INCORPORATION: MN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13143 FILM NUMBER: 06632494 BUSINESS ADDRESS: STREET 1: 5540 PIONEER CREEK DRIVE CITY: MAPLE PLAIN STATE: MN ZIP: 55359-9003 BUSINESS PHONE: 7634795300 8-K 1 a5084952.txt INNOVEX, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): February 15, 2006 Innovex, Inc. ----------------------------------- (Exact name of Registrant as Specified in its Charter) Minnesota ----------------------------------- (State Or Other Jurisdiction Of Incorporation) 000-13143 41-1223933 - -------------------------------- ------------------------------------- (Commission File Number) (I.R.S. Employer Identification No.) 5540 Pioneer Creek Drive Maple Plain, MN 55359 - -------------------------------- ------------------------------------- (Address Of Principal Executive Offices) (Zip Code) (763) 479-5300 ----------------------------------- Registrant's Telephone Number, Including Area Code Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Items under Sections 2-4 through 6-8 are not applicable and therefore omitted. ITEM 1.01 Entry into a Material Definitive Agreement. Director Compensation On February 16, 2006, Innovex, Inc. (the "Company") approved the payment of a monthly retainer of $1,000 in addition to the current amounts paid to directors. The monthly retainer was recommended by the Compensation Committee of the Board of Directors of the Company and approved by the Board of Directors. Employment Agreement with Executive Officers Effective February 16, 2006, Innovex, Inc. (the "Company") entered into an employment agreement with Keith Foerster, the Company's Senior Vice President, Development and Sales. Effective February 16, 2006, the Company entered into a similar employment agreement with Terry Dauenhauer, the Company's Senior Vice President and Chief Operating Officer. The employment agreements, a form of which is attached hereto as Exhibit 10.1 (the "Agreement"), were approved by the Compensation Committee of the Board of Directors and the Board of Directors of the Company. Below is a description of the Agreement, which is qualified in its entirety by the Agreement itself. The only difference in the Agreement between the Company and each executive is the effective date of the employment agreement and annual base salary. The Agreement sets Mr. Foerster's annual base salary at $200,000 per year and Mr. Dauenhauer's annual base salary at $224,000 per year, with such base salaries payable on a semi-monthly basis. In this Current Report on Form 8-K, Mr. Foerster and Mr. Dauenhauer will be referred to as the "Executive." In addition to the base salary referred to above, the Agreement provides that the Executive will be eligible for a bonus award pursuant to a bonus plan determined by the Board and subject to the terms of the applicable bonus plan. Any bonus awarded may take the form of cash or stock options, or a combination thereof, and must be paid within the two and a half months following the end of the fiscal year. All bonus awards are subject to the Executive's continued employment with the Company through the last day of the fiscal year upon which the bonus is based, except where the Executive's employment is terminated by the Company for good cause or by the Executive for good reason, as such terms are defined in the Agreement. The Company will also reimburse or advance the Executive his ordinary business expenses and provide the Executive with an annual vehicle allowance. The Executive is also eligible for such other employee benefits as are applicable to other employees of the Company. The Executive reports to the Company's Chief Executive Officer. The Executive may resign upon 30 days advance written notice to the Company's Chief Executive Officer. During the 30 day notice period, the Executive agrees to provide reasonable assistance in hiring and training his replacement, as requested by the Company. If the Executive terminates his employment for good reason or if the Company terminates the Executive's employment for other than good cause and such termination is not related to a change in control, the Executive will continue to be paid his regular salary and employee benefits for 12 months after the date of termination of employment. If the Executive's employment is terminated without good cause or the Executive resigns for good reason within 12 months following a change of control, as such term is defined in the Agreement, the Executive will receive continuation of his base salary for 12 months, payment of the employer share of his group health and dental premiums for up to 12 months and immediate 100% vesting of any unvested stock options. The change of control benefits are contingent upon the Executive not resigning within 90 days following a change of control. If the Executive or the Company would be subject to excise tax or would be disallowed certain tax deductions, the Company will reduce or eliminate the change in control payments to that neither the Executive or the Employee is subject to such excise tax or disallowance of certain tax deductions. If the Executive's employment is terminated by reason of the Executive's disability, as that term is defined in the Agreement, the Executive will receive those benefits available to him under disability plans sponsored by the Company, except that if the Executive is covered under a group short-term disability plan, the Company will continue to pay the Executive 40% of his base salary for the duration of the short-term disability period and if the Executive is covered by a long-term disability plan, the Company will not make any additional payments to the Executive. If the Executive's employment terminates by reason of his death, the Executive's estate will be entitled to the biweekly installment of his base salary otherwise due and payable at the end of the biweekly period in which the Executive dies. All severance, change of control or other salary continuation benefits will be reduced by other benefits payable to the Executive by the Company and any unemployment benefits received by the Executive and will be subject to the Executive entering into a standard release agreement in favor of the Company and subject to the Executive's compliance with his obligations as to the Company's confidential information, assignment of inventions, non-competition, non-solicitation and non-interference. ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On February 16, 2006, the Governance Committee of the Board of Directors of the Company recommended and the Board of Directors approved the appointment of Kenneth Roering to the Board of Directors. Mr. Roering was also appointed to serve on the Audit Committee and Compensation Committee of the Board of Directors of the Company. On February 21, 2006, the Company issued a press release regarding the appointment of Mr. Roering, attached hereto as Exhibit 99.1. Additionally, on February 15, 2006, Townsend H. Porter, Jr. resigned from the Board of Directors of the Company for reasons unrelated to a disagreement over the Company's operations, policies or practices. ITEM 9.01 Financial Statements And Exhibits. Exhibit No. Description - ----------- ------------------------------------------------------------- 10.1 Form of Employment Agreement effective February 16, 2006 between Innovex, Inc. and certain executive officers ** 99.1 Press Release issued February 21, 2006 ** Compensatory plan, contract or arrangement. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INNOVEX, INC. By: /s/ Thomas Paulson ---------------------------------- Thomas Paulson Senior Vice President and Chief Financial Officer Date: February 20, 2006 EX-10 2 a5084952ex10-1.txt EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement is entered into between Innovex, Inc., a Minnesota corporation (collectively, with its subsidiaries, affiliates and parent companies, "Innovex" or the "Company"), and [Terry Dauenhauer/Keith Foerster] ("Employee") as of February 16, 2006. WHEREAS, the Employee has been employed as Innovex's Senior Vice-President since [January 12, 2004/May 25, 1992], Innovex desires to continue to employ the Employee in these capacities and the Employee agrees to continue his employment under the terms and conditions of this Agreement; and WHEREAS, Innovex is providing consideration to the Employee consisting of increased protection in the event of a Change in Control, enhanced severance benefits, its willingness to retain him as its employee, its payment of compensation and provision of benefits to him, his exposure and access to its valuable Customers and other business contacts and trade secrets, his specialized training in connection with his employment, and all other benefits associated with this Agreement and his employment with Innovex. NOW THEREFORE, in consideration of the mutual covenants, terms and conditions herein contained, it is hereby agreed by and between the parties hereto as follows: DEFINITIONS Change in Control. A Change in Control shall be deemed to have occurred if any of the following occur: (1) Any "Person" (as defined in Section 13(d) of the Securities Exchange Act of 1934, as amended, or any successor statute thereto (the Exchange Act)) acquires or becomes a beneficial owner (as defined in Rule 13d-3 or any successor rule), directly or indirectly, of securities of the Company representing 20% or more of the combined voting power of the Company's then outstanding securities entitled to vote generally in the election of directors (Voting Securities) or 20% or more of the outstanding shares of common stock of the Company (Common Stock), provided, however, that the following shall not constitute a Change in Control: (a) any acquisition or beneficial ownership by the Company or a subsidiary of the Company; (b) any acquisition or beneficial ownership by any employee benefit plan (or related trust) sponsored or maintained by the Company or one or more of its subsidiaries; (2) Continuing Directors shall not constitute a majority of the members of the Board of Directors of the Company. Continuing Directors shall mean: (a) individuals who, on the date hereof, are directors of the Company, (b) individuals elected as directors of the Company subsequent to the date hereof for whose election proxies shall have been solicited by the Board of Directors of the Company, or (c) any individual elected or appointed by the Board of Directors of the Company to fill vacancies on the Board of Directors of the Company caused by death or resignation (but not by removal) or to fill newly-created directorships, provided that a Continuing Director shall not include an individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the threatened election or removal of directors (or other actual or threatened solicitation of proxies or consents) by or on behalf of any person other than the Board of Directors of the Company; (3) Consummation of a reorganization, merger or consolidation of the Company (other than a merger or consolidation with a subsidiary of the Company), unless immediately following such reorganization, merger or consolidation, all or substantially all of the persons who were the beneficial owners, respectively, of Voting Securities and Common Stock immediately prior to such reorganization, merger or consolidation beneficially own, directly or indirectly, 51% or more respectively of (a) the combined voting power of the then outstanding Voting Securities entitled to vote generally in the election of directors, and (b) the then outstanding shares of Common Stock of the corporation resulting from such reorganization, merger or consolidation in substantially the same proportions as their ownership of the Voting Securities and Common Stock, as the case may be, immediately prior to such reorganization, merger or consolidation; or (4) Consummation of a liquidation or dissolution of the Company or the sale or other disposition of all or substantially all of the assets of the Company (in one or a series of transactions), other than to a wholly-owned subsidiary of the Company. Notwithstanding anything stated above, a Change of Control event shall not be deemed to occur with respect to the Employee if the acquisition or beneficial ownership of the 20% or greater interest referred to in (1) is by the Employee or a group, acting in concert, that includes the Employee or a majority of the then combined voting power of the then outstanding Voting Securities (or voting equity interests) of the surviving corporation or of any corporation (or other entity) acquiring all or substantially all of the assets of the Company shall, immediately after a reorganization, merger, consolidation or disposition of assets referred to in (3) or (4) of this definition, be beneficially owned, directly or indirectly, by the Employee or by a group, acting in concert, that includes the Employee. Conflicting Organization. A Conflicting Organization is any person or organization (including Innovex Customers and Vendors) engaged in or about to become engaged in, research, development, production, marketing, leasing, selling or servicing of a Conflicting Product in any market in which Innovex is doing or about to be doing business as of the Employee's termination date. Conflicting Product. A Conflicting Product is any product, product line, process, system or service (including any component thereof or research to develop information useful in connection with a product or service) which is the same, similar to or competitive with (whether based on similar or alternative technologies) any product, product line, process, system or service which the Employee or any person under the Employee's direct or indirect supervision designed, developed, marketed, promoted, sold, serviced, provided or worked on in any other capacity on behalf of Innovex during the two years preceding the Employee's termination date, including any product, product line, process, system or service in existence or under development or about which the Employee possesses Confidential Information. Customer or Vendor. A Customer or Vendor is any person or entity with whom the Employee or anyone under his direct or indirect supervision had any direct or indirect contact on behalf of Innovex in connection with Innovex's products or services. Disability. The Employee's Disability shall occur if he becomes unable to substantially, with or without reasonable accommodation, perform his duties under this Agreement, by reason of any medically determinable physical or mental impairment, for at least 180 consecutive days. The existence of a Disability will be determined pursuant to the standards for entitlement for long-term disability benefits set forth in Innovex's Long-Term Disability Plan. 2 Good Cause. Good Cause shall exist if the Employee has (a) engaged in theft, embezzlement, other act of dishonesty, moral turpitude, or any willful violation of the Securities Exchange Act of 1934, as amended; (b) materially breached any of his obligations under this Agreement; or (c) engaged in gross mismanagement or gross negligence in the performance of his duties hereunder. With respect to (b) and (c), Employee shall be given written notice of the facts believed to constitute grounds for termination and a 30-day period in which to cure those grounds to the satisfaction of the Board. Good Reason. Good Reason shall exist if the Employee experiences (a) a material reduction in his compensation or responsibilities (except if such change is made available as reasonable accommodation in the event of Employee's Disability or other inability to perform his duties due to a physical or mental condition) or (b) a requirement that he relocate to a workplace more than 50 commuting miles from his principal residence, provided however that Good Reason shall not exist following a Change in Control if the Employee retains responsibility for a division, subsidiary or other operational unit or entity that is substantially similar to or larger than Innovex as it existed prior to the Change in Control. Good Will. Good Will is Innovex's valuable Customer, Vendor and other industry relationships which it is the responsibility of the Employee and other Innovex employees to maintain, develop, nurture, improve and expand in connection with the products and services provided to said Customers by Innovex or purchased from said Vendors. 1. Employment and Term. Innovex agrees to employ the Employee as its [Senior Vice-President & Chief Operating Officer/ Senior Vice President, Development and Sales], reporting to the Chief Executive Officer ("CEO") and the Employee agrees to serve Innovex in such capacities on the terms and conditions set forth herein for the period commencing on the date of this Agreement and continuing until terminated by the Employee or Innovex in accordance with paragraph 5. 2. Duties. The Employee shall be responsible for the management of [manufacturing operations, process engineering, supply chain management, human resources management/new product development, customer sales and service] and such other duties and responsibilities as may be assigned to him by the CEO. Employee shall faithfully and diligently do and perform all such acts and duties and furnish such services for Innovex as the CEO or Board shall direct, promote the interest and welfare of Innovex and its business, be familiar with Innovex's policies that relate to his duties and abide by these policies, and not intentionally do anything which may cause loss or damage to Innovex, its business, business reputation or Good Will. He shall devote his full time, energy and skill to the business of Innovex, except for vacations, absences made necessary because of illness, and service on other corporate, civic, or charitable boards or committees not significantly interfering with his duties hereunder. Employee shall not engage in any other business or nonprofit activity during his employment with Innovex except as may be approved in advance by the Board, provided however that Employee shall not be precluded from owning up to 5% of the issued and outstanding capital stock or other interest of an entity which is not a Customer, Vendor or Conflicting Organization. 3 3. Compensation. In return for his services to Innovex, Employee shall receive compensation and benefits which shall include the following: 3.1 Salary. The Employee shall receive a semi-monthly base salary of [$9,333.33 ($224,000 annualized)/ $8,333.33 ($200,000 annualized)]. Salary reviews shall occur at least once per year, and the Board shall grant Employee such salary increases based upon the Employee's performance as the Board, in its sole discretion, deems appropriate. 3.2 Bonus. For each fiscal year during Employee's employment, Employee will be eligible for a bonus award pursuant to a bonus plan determined by the Board. Employee's 2005 bonus plan is attached as Exhibit 1. Bonus awards will be subject to the terms of the applicable bonus plan and are conditioned upon Employee's continued employment with Innovex through the last day of the fiscal year on which the bonus is based except as otherwise permitted under 5.2. A determination as to whether the bonus objectives have been met will be made, in the sole discretion of the Board, by comparing Employee's and Innovex's actual performance for the fiscal year to the performance measures defined in the bonus plan at the beginning of the fiscal year. A bonus awarded pursuant to this 3.2 may take the form of cash or stock options, subject to the applicable stock option plans, or a combination of the two. A bonus awarded to the Employee for any fiscal year will be paid within two and a half months following the end of said year. 4. Benefits and Expenses. 4.1 Employee Benefits. The Employee shall be eligible for such employee benefits as are offered by Innovex to other employees. Innovex may terminate any or all such plans at any time and may choose not to adopt any additional plans. Employee's rights under any Innovex plans and policies shall be governed solely by their terms. Employee shall be eligible for four weeks of vacation annually, subject to the parameters set forth in Innovex's vacation policy. 4.2 Reimbursable Business Expenses. In addition to salary and other benefits, Innovex will advance or reimburse Employee for any ordinary, necessary and reasonable expenses incurred by him in the course of his employment. Innovex shall reimburse the Employee upon his submission of any records and documentation required to substantiate said expenses. 4.3 Company Vehicle. Innovex will provide Employee with an annual vehicle allowance to be prorated over the Company's regular pay periods throughout the year. Employee's vehicle allowance will be in accordance with and subject to the Company Vehicle Policy (Exhibit 2). 4.4 Indemnification. Innovex will indemnify the Employee from loss and expenses arising out of his conduct as an officer of Innovex to the fullest extent permitted by the Company's corporate articles, by-laws, Board resolutions, applicable insurance policy and Minnesota law. 5. Termination of Employment. 4 5.1 Voluntary Resignation. The Employee may resign his employment with Innovex for any reason effective upon 30 days' advance written notice to the CEO. During the notice period he will provide all reasonable aid and assistance in hiring, training, and introducing his replacement as may be requested by Innovex and will undertake such other responsibilities as Innovex may direct. Alternatively, Innovex reserves the right to terminate Employee's employment, effective upon written notice to Employee, at any time during the notice period provided, however, that base salary and Innovex's share of his group health, dental and life premiums as may be in effect, subject to the terms of the plans, applicable law and 5.6 and 5.7 hereof, will continue for the duration of the notice period. No other benefits will be payable to Employee during the notice period. 5.2 Involuntary Termination and Resignation for Good Reason. Employee's employment may be terminated (a) by Innovex for other than Good Cause, effective upon the date specified in Innovex's written notice of termination to Employee, (b) by Innovex for Good Cause, effective upon Employee's receipt of Innovex's written notice of termination, or (c) by the Employee for Good Reason, effective upon the Board's receipt of Employee's written notice of termination, which shall include a detailed explanation as to why he believes Good Reason exists. If Employee's employment is terminated for other than Good Cause or for Good Reason under this 5.2 and the termination is not related to a Change in Control, base salary and the employer share of Employee's Innovex group health and dental premiums will continue to be paid for 12 months from Employee's termination date, subject to 5.6, 5.7 and Employee's other obligations hereunder. In addition, if the Employee's termination occurs partway through a fiscal year, the Board may award a prorated bonus to Employee if (i) Employee would have received a bonus if he had remained in Innovex's employ for the full fiscal year and (ii) the Board determines that Employee's contribution to Innovex prior to his termination date warrants a prorated bonus award. Only the benefits described in this 5.2 will be payable to Employee during the severance period. Termination for other than Good Cause shall include non-Good Cause termination due to performance issues and any other non-Good Cause termination not described in 5.3, 5.4 or 5.5. If the Employee's termination is for Good Cause, his base salary and benefits will be paid only through his termination date. 5.3 Change in Control. 5.3.1. If Employee's employment is terminated without Good Cause or Employee resigns for Good Reason within 12 months following a Change in Control, he will receive (a) continuation of his base salary for 12 months, (b) payment of the employer share of his group health and dental premiums for up to 12 months, and (c) immediate 100% vesting of any unvested stock options (the "Parachute Payments"). Approval of this Agreement by the Compensation Committee of the Board shall be deemed approval of the vesting of options as provided in the immediately preceding sentence for all purposes under Innovex stock purchase and stock option plans and programs. Notice of termination or resignation shall be in writing to the applicable party. Employee's right to the benefits provided in this 5.3.1 is contingent upon him not resigning his employment from Innovex within 90 days following a Change in Control, the requirements of 5.6 and 5.7, and his compliance with his other obligations hereunder. 5.3.2. If the Employee or Innovex would be subject to excise tax or denial of deduction under Sections 280G and 4999 of the Internal Revenue Code as a result of the Parachute Payments described in 5.3.1, Innovex shall reduce or eliminate such payments to the extent necessary to reduce the aggregate "present value" (as defined in Section 280G(d)(4) of the Code) of such payments to $100 less than an amount equal to three times Employee's "base amount" (as defined in 280G(b)(3)(a) and (d)(1) and (2) of the Code) so that Employee is not subject to tax under Section 4999 and no Innovex deduction is disallowed pursuant to Section 280G(a). 5 5.4 Disability. The Employee's employment will terminate if he comes under a Disability, is unable to perform his duties hereunder and Innovex is unable, because of undue hardship, to provide reasonable accommodations to enable him to continue his employment. Accommodations offered by Innovex could include change of responsibilities or title. In the event of Employee's Disability, his benefits will be those available under group short-term and long-term disability plans sponsored by Innovex, except as provided in the following sentence. If Employee is covered under a group short-term disability plan, Innovex will continue to pay 40% of his base salary for the duration of his short-term disability period unless the plan would cause this amount to reduce his short-term disability benefits. If he is covered by a long-term disability plan, he will not be eligible for any additional payments from Innovex during the period of such coverage. Innovex will pay Employee's group health and dental premiums during any period of group short or long term disability coverage for up to 18 months, to the extent such premiums are not paid under any group health, disability or other policy maintained by Innovex under which the Employee is a Participant, Employee is not eligible to participate in any other group plans, and Employee continues to be eligible to participate in said Innovex plans. 5.5 Death. If Employee dies during his employment, Innovex will pay his estate the biweekly installment otherwise due and payable at the end of that biweekly period in which the Employee shall have died, and thereafter no further compensation shall be payable by Innovex to Employee hereunder, except for normal and customary life insurance benefits and vested pension benefits, if any. 5.6 Payment Conditions. Any payments made to Employee pursuant to 5.1, 5.2, 5.3 or 5.4 will be reduced by (a) any other benefits payable to Employee directly or indirectly from Innovex (not including Social Security benefits), such as payments under any disability plan or policy the premiums of which have been paid by Innovex or any severance or other payments to Employee under any company plan or policy and (b) unemployment benefits received by the Employee. In addition, as a condition of receiving any such payments, Employee will be required to sign a standard release agreement in which he releases all claims which he might have against Innovex or any affiliate, employee, shareholder, director, officer or agent of Innovex (along with other standard releasees affiliated with Innovex). Innovex will provide said release agreement to the Employee at the time he is notified of his termination without Good Cause, following his notice of resignation for Good Reason or during the notice period following his voluntary resignation. As part of the release agreement, Employee will be required to (i) cooperate with Innovex with respect to any business matters about which he has knowledge, including any litigation or threatened litigation, (ii) not cooperate with any plaintiffs or claimants against Innovex unless required by law to do so, (iii) not make negative or derogatory comments about Innovex or any other releasee and (iv) affirm his post-termination obligations under this Agreement. The release agreement will also provide that if the Employee violates any obligation of his under paragraphs 6, 7 or 8 of this Agreement, all payments and benefits to him will immediately cease. The release agreement is attached as Exhibit 3, provided however that Exhibit 3 may be revised to comply with current law or to provide for unforeseen circumstances. 5.7 Group Health and Dental Coverage. The Employee's right to Innovex's payment of the employer share of his group health and dental premiums is subject to his timely election to continue his coverage under COBRA and applicable state law, his continued eligibility under the plans, his lack of eligibility to participate in any other group plans, and deduction of his share of the premiums from his severance payments. 6 6. Confidentiality. During his employment with Innovex, the Employee has had and will continue to have access to and become acquainted with trade secrets and other proprietary and confidential information owned by Innovex and used in the operation of Innovex's business. "Trade secrets and other proprietary and confidential information" shall mean any information or knowledge possessed by Innovex which is not generally known to or readily ascertainable by outside parties who can obtain economic value from its use or disclosure. This shall include, without limitation, inventions, discoveries, ideas, know-how, research and development information, designs, specifications, formulas, patterns, compilations, computer programs, devices, methods, techniques, processes, data, improvements, ideas, algorithms, computer processing systems, drawings, proposals, job notes, reports, records, specifications, information concerning any matters relating to the business of Innovex and any of its customers, vendors, customer and vendor contacts, licenses, the prices it obtains or has obtained for the licensing of its software products and services, or any other non-public information concerning the business of Innovex and its good will. Confidential information also includes the terms of this Agreement and any release agreement provided to Employee by Innovex or entered into between the Employee and Innovex, except as otherwise provided in 6.1 or 8.2. 6.1 Nondisclosure. Employee shall not disclose or use in any manner, directly or indirectly, any such trade secrets or other proprietary and confidential information either during the term of his employment or at any time thereafter, except as required (a) in the course of his employment with Innovex or (b) by applicable law, including the Exchange Act, contingent upon establishment of confidentiality protections satisfactory to Innovex. 6.2 Information Disclosed Remains Company Property. All ideas, concepts, information, and written material disclosed to Employee by Innovex or acquired from a Customer or prospective Customer of Innovex, are and shall remain the sole and exclusive property and proprietary information of Innovex or such Customers, and are disclosed in confidence by Innovex or permitted to be acquired from such Customers in reliance on Employee's agreement to maintain them in confidence and not to use or disclose them to any other person except in furtherance of Innovex's business. 6.3 Return of Materials. Employee agrees that, upon request of Innovex or upon termination of employment, Employee shall turn over to Innovex originals and any copies of all documents, files, disks or other computer media, or other property or material in his possession or under his control that (a) may contain or be derived from ideas, concepts, creations, or trade secrets and other proprietary and confidential information as described in this section or (b) are connected with or derived from Employee's services to Innovex. Employee agrees to certify in writing that he has complied with this 6.3 at the time of his termination of employment. 6.4 Prohibition. Employee certifies and agrees that to the best of his knowledge he (a) does not possess confidential or proprietary documents or property of any prior employer and (b) while in Innovex's employ, he has not and will not use or disclose the protected trade secrets of any prior employer or other entity. Trade secrets for purposes of this prohibition are defined in (i) Minnesota Statutes Section 325C.01, Subd. 5 and (ii) any agreement with a prior employer or any other person or entity in which the Employee is obligated not to use or disclose that person or entity's trade secrets. The Employee certifies that he has provided a copy of any such contractual obligation to Innovex. 7 7. Inventions and Creations. Any and all inventions, discoveries, improvements, or creations (collectively, "Inventions") made or conceived by Employee during the period of his employment by Innovex shall be the property of Innovex. Employee hereby assigns to Innovex all of his rights to any such Inventions and agrees to promptly disclose any such Inventions in writing to Innovex. Employee further agrees to execute and assign any and all proper applications, assignments and other documents and to render all assistance reasonably necessary to apply for patent, copyright or trademark protection in all countries. 7.1 Exceptions. Paragraph 7 does not apply to an Invention for which no equipment, supplies, facility or trade secret information of Innovex was used and which was developed entirely on Employee's own time and (a) which does not relate (i) directly to the business of Innovex or (ii) to Innovex's actual or demonstrably anticipated research or development; or (b) which does not result from any work performed by Employee for Innovex. Exhibit 3 hereto constitutes a complete list of the inventions made by Employee prior to employment by Innovex as to which he has at least partial ownership. Innovex shall have no claim of right or title to the inventions listed on Exhibit 3. 7.2 Definition of Inventions. For purposes of this Agreement, the term "Inventions" shall mean discoveries, improvements, and ideas (whether or not shown or described in writing or reduced to practice) and works of authorship, whether or not patentable or copyrightable, which (a) relate directly to the business of Innovex; (b) relate to Innovex's actual or demonstrably anticipated research or development; or (c) result from any work performed by Employee for Innovex, or for which equipment, supplies, facilities or trade secret information of Innovex is used, or which is developed on Innovex time. 7.3 Non-Covered Inventions. Should the Employee make a discovery, improvement or Invention that is not covered by the provisions of this Agreement (a "Non-Covered Invention"), the Employee may, at his sole option, disclose the Non-Covered Invention to Innovex and Innovex shall then have a right of first refusal to enter into a license agreement with Employee to acquire rights thereunder. If negotiations extend for more than six months from the date of disclosure to Innovex, Employee shall be free to submit the Non-Covered Invention to others without obligation to Innovex and with respect to such Non-Covered Invention. 8. Non-Competition, Non-Solicitation and Non-Interference. 8.1 Duty of Loyalty. The Employee acknowledges that he has a duty of loyalty to Innovex during his employment. Therefore, during his employment, he will not directly or indirectly plan, organize, own, perform services for or in any way associate with any Conflicting Organization or conspire with others to do so. 8 8.2 Non-Competition. For one year following the termination of his employment with Innovex for any reason, the Employee will not directly or indirectly, as a shareholder, director, officer, employee, owner, agent, associate, consultant or in any other capacity, plan, organize, own, perform services for or in any other way associate with any Conflicting Organization. During this one-year period, the Employee also agrees to provide (a) a copy of this agreement to any prospective employer or other person or entity for which he intend to perform services and (b) written notification to the CEO of Innovex of any new employment or other business engagement of his. Because Innovex has no interest in the Employee's post-Innovex activities if those activities do not involve Innovex's Confidential Information or Good Will and are not otherwise harmful to Innovex, Innovex's CEO, in his sole discretion, will consider modification of the obligation in this 8.2 with respect to a specific position with a specific employer, entity or person following Employee's written request for same and his cooperation in providing any requested information in connection with such request. The CEO will agree to the requested modification or a variation thereof only if he determines that the modification will not be harmful to Innovex's business interests and will not violate its protectible interests in its Confidential Information and Good Will. The CEO will notify the Employee in writing of his decision, which will be final. 8.3 Non-Solicitation. For one year following the termination of Employee's employment with Innovex for any reason, he agrees that he will not, directly or indirectly, on his own behalf or on behalf of any Conflicting Organization, solicit: 8.3.1 any Customer with whom he had contact during the two-year period prior to his termination date or about which he possesses Confidential Information, for the purpose of directly or indirectly (a) marketing, promoting or encouraging the use of a Conflicting Product, (b) providing advice or assistance in connection with the marketing, promotion or use of a Conflicting Product, or (c) attempting to interfere with, or preventing or diverting the sale or purchase of, any product being designed, developed, sold or marketed by Innovex; 8.3.2 any Innovex employee or agent to terminate his or her employment or agency with Innovex; or 8.3.3 any Vendor that provides an exclusive or unique service or product to Innovex for the purpose of obtaining similar products or services for a Conflicting Organization. 8.4 Employee's Acknowledgments and Agreements. Employee acknowledges and agrees that the products developed by Innovex are or are intended to be marketed and licensed to Customers in various markets throughout the world. Employee further acknowledges and agrees to the reasonableness of the covenants contained in this Section 8, including the reasonableness of the geographic area and duration of time which are part of said covenant. Employee also acknowledges and agrees that this covenant will not preclude Employee from becoming gainfully employed following termination of employment with Innovex. Employee certifies that he is not currently subject to a noncompetition agreement with a former employer which prohibits him from working for Innovex. 8.5 Time Periods After a Change in Control. If Employee's employment terminates pursuant to 5.3.1, the time periods in 8.2 and 8.3 shall be extended from one year to 18 months. 9. Miscellaneous Provisions. 9 9.1 Remedies, Injunction. In the event of a breach or threatened breach by Employee of any provision of this Agreement which could cause irreparable injury and damage to Innovex not compensable by money damages, Employee agrees that Innovex, in addition to and not in limitation of any other rights, remedies or damages available to Innovex at law or in equity, shall be entitled to injunctive and other equitable relief to prevent or restrain any such breach by Employee or by Employee's partners, agents, representatives, servants, employees, and/or any and all persons directly or indirectly acting for or with Employee. 9.2 Severability. If any provisions of this Agreement are held to be invalid or unenforceable in whole or in part, those provisions to the extent enforceable and all other provisions shall nevertheless continue to be valid and enforceable as though the invalid or unenforceable parts had not been included in this Agreement. If any provision relating to the time period or scope of a restriction shall be declared by a court of competent jurisdiction to exceed the maximum time period or scope such court deems reasonable and enforceable, then the time period or scope of the restriction deemed reasonable and enforceable by the court shall become and shall thereafter be the maximum time period or the applicable scope of the restriction. 9.3 Governing Law. This Agreement shall be construed and enforced according to Minnesota law, except where federal law applies. All legal actions arising under this Agreement shall be instituted in, and both Innovex and Employee consent to, the jurisdiction of the courts of Hennepin County, Minnesota or the U.S. District Court for the District of Minnesota. 9.4 Survivability. The covenants and agreements of paragraphs 5 and 9, where applicable, and paragraphs 6, 7 and 8 of this Agreement shall survive the termination of the Employee's employment for any reason and shall not be terminated by a Change in Control, including but not limited to any merger or consolidation whereby Innovex is not the surviving corporation or any transfer of substantially all the assets of Innovex, unless no transferee or successor continues to carry on the business activities of Innovex. In the event of any such event , the provisions of this Agreement shall inure to the benefit of and be binding upon the surviving, resulting or transferee entity . 9.5 Integration. The terms of this Agreement constitute the entire agreement between Innovex and the Employee on the subjects addressed herein and supersede any previous conflicting oral or written communications, representations, policies or agreements. 9.6 Amendment or Termination. This Agreement may not be terminated, amended, or modified in any way, except in writing signed by both Innovex and Employee. 9.7 Waiver. Innovex's waiver or failure to enforce the terms of this Agreement or any similar agreement in one instance shall not constitute a waiver of its rights hereunder with respect to other violations of this or any other agreement. 9.8 Tax Withholding. Innovex will withhold from any payment of benefits under this Agreement (and forward to the appropriate taxing authority) any taxes required to be withheld under applicable law. 9.9 Agreement Read, Understood and Deemed Reasonable. Employee has carefully read and considered all provisions of this Agreement and agrees that all of the restrictions set forth are reasonable and reasonably required for the protection of Innovex's interests. 10 AGREED: Dated:_____________ -------------------------------------------- [Terry Dauenhauer/Keith Foerster] INNOVEX, INC. Dated:_____________ /s/ Raj Nooyi -------------------------------------------- Raj Nooyi Chairman of the Compensation Committee 11 EX-99.1 3 a5084952ex99-1.txt EXHIBIT 99.1 Exhibit 99.1 Innovex Announces Board of Directors Changes; Names Kenneth J. Roering to Board, Townsend H. Porter Resigns MAPLE PLAIN, Minn.--(BUSINESS WIRE)--Feb. 21, 2006--Innovex (Nasdaq:INVX) today announced the addition of Kenneth J. Roering, 62, to the company's Board of Directors. Dr. Roering is currently Professor of Marketing in the Carlson School of Management of the University of Minnesota and Executive Vice President, Strategic Management, Marshall BankFirst Corp. He occupied the prestigious Pillsbury Company-Paul S. Gerot Chair in Marketing from 1983-2002. He served as Chairman of the Marketing Department at the University of Minnesota for five years. Dr Roering has served as visiting professor or distinguished guest lecturer at a number of universities including Northwestern University, Harvard University, University of Michigan, University of Virginia, University of Illinois, University Jean Moulin (Lyon, France) and the Warsaw School of Economics (Poland). Innovex also announces the resignation of Townsend H. Porter from its Board of Directors effective February 15, 2005. Mr. Porter has been a member of the Innovex Board since January 2005. "I've recently acquired a vineyard in Napa Valley, California and the time commitment necessary to make this family business successful prevents me from devoting the appropriate amount of time as a director of Innovex," stated Porter. "Innovex has made excellent progress reducing its cost structure and improving its new product development process during the past year and I am confident the company will continue to improve and be successful in the future." "We greatly appreciate Tom's contributions during the past year, especially in the areas of technology and new product development and we will sorely miss his input," stated William P. Murnane, Innovex's President and Chief Executive Officer. "We wish him great success as he pursues a life long dream and passion." "We are delighted to welcome an executive of Dr. Roering's caliber to Innovex's Board," stated Murnane. "Ken's broad management and board experience will help us enhance our growth strategy and develop industry leading products. We are very pleased and privileged to have him join our Board of Directors." Dr. Roering has been a member of the Board of Directors of several private and public companies during the past 20 years and currently serves on the Board of Directors of Arctic Cat, Transport America and Rave Sports. His primary areas of activity are business strategy, marketing strategy, marketing management, and new product development. He obtained his doctorate from the University of Iowa in 1972. Dr. Roering will also serve on Innovex's audit and compensation committees. Innovex, Inc. is a leading manufacturer of high-density flexible circuit-based electronic interconnect solutions. Innovex's products enable the miniaturization and increasing functionality of high technology electronic devices. Applications for Innovex's products include data storage devices such as hard disk drives and tape drives, liquid crystal displays for mobile telecommunication devices, flat panel displays and printers. Innovex is known worldwide for its advanced technology and world class manufacturing. Except for historical information contained herein, the matters discussed in this release are forward looking statements that involve risks and uncertainties, including the timely availability and acceptance of new products, the impact of competitive products and pricing, effect of world-wide economic conditions on flexible circuit demand, changes in manufacturing efficiencies and other risks detailed from time to time in the company's reports filed with the Securities and Exchange Commission. CONTACT: Innovex, Inc., Maple Plain Tom Paulson, 763-479-5300 or Douglas W. Keller, 763-479-5300 -----END PRIVACY-ENHANCED MESSAGE-----